Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

BACKGROUND: Approximately 80% of patients with locally advanced pancreatic cancer (LAPC) are treated with chemotherapy, of whom approximately 10% undergo a resection. Cohort studies investigating local tumor ablation with radiofrequency ablation (RFA) have reported a promising overall survival of 26...

Descripción completa

Detalles Bibliográficos
Autores principales: Walma, M. S., Rombouts, S. J., Brada, L. J. H., Borel Rinkes, I. H., Bosscha, K., Bruijnen, R. C., Busch, O. R., Creemers, G. J., Daams, F., van Dam, R. M., van Delden, O. M., Festen, S., Ghorbani, P., de Groot, D. J., de Groot, J. W. B., Haj Mohammad, N., van Hillegersberg, R., de Hingh, I. H., D’Hondt, M., Kerver, E. D., van Leeuwen, M. S., Liem, M. S., van Lienden, K. P., Los, M., de Meijer, V. E., Meijerink, M. R., Mekenkamp, L. J., Nio, C. Y., Oulad Abdennabi, I., Pando, E., Patijn, G. A., Polée, M. B., Pruijt, J. F., Roeyen, G., Ropela, J. A., Stommel, M. W. J., de Vos-Geelen, J., de Vries, J. J., van der Waal, E. M., Wessels, F. J., Wilmink, J. W., van Santvoort, H. C., Besselink, M. G., Molenaar, I. Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082784/
https://www.ncbi.nlm.nih.gov/pubmed/33926539
http://dx.doi.org/10.1186/s13063-021-05248-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082784/
https://www.ncbi.nlm.nih.gov/pubmed/33926539
http://dx.doi.org/10.1186/s13063-021-05248-y

Ejemplares similares